 |
|
A Highly Sensitive Method for Clopidogrel Analysis
Sponsored By: Jennifer L. Simeone, Paul D. Rainville, Robert S. Plumb, Waters Corporation
A high-sensitivty method for the analysis of clopidogrel and its carboxylic metabolite was developed using solid-phase extraction along with UPLC/MS/MS that achieved an LLOQ of 1 pg/mL in human plasma.
|
|
Quantification of Budesonide Using UPLC and Xevo TQ-S
Sponsored By: Tirupateswara Rao B., Sudarshan Mantha, and Gopal Vaidyanathan, Waters Corporation
The Regulated BIoanalysis System Solution from Waters provides a highly sensitive method for quantification of budesonide in plasma, as well as high selectivity and throughput. |
|
Compound Optimization for MRM Analysis
Sponsored By: Robert S. Plumb, Stuart Chadwick, Jennifer Simeone, and Paul D. Rainville, Waters Corporation
Compound optimization facilitates the fast, simple development of a multiple reaction monitoring (MRM) method for one or more compounds. The results generated can be stored within the scientific library, allowing simple method generation and sharing of information between scientists. |
|
Gradient and Temperature Optimization
Sponsored By: Robert S. Plumb, Stuart Chadwick, Jennifer Simeone, and Paul D. Rainville, Waters Corporation
Maximize bioanalytical assay productivity and throughput using promoted parameters and template acquisition, which enables the rapid simple screening and optimization of gradient and column temperature conditions. |
|
Promoted Parameters for Bioanalytical Method Development
Sponsored By: Paul Rainville, Waters Corporation
Rapidly acquire data needed to select optimal LC and MS conditions for a bioanalytical assay; a greater number of parameters can be evaluated for optimal method selection, while improving productivity. |
|
LC Mobile Phase Screening
Sponsored By: Robert S. Plumb, Stuart Chadwick, and Paul D. Rainville, Waters Corporation
Rapidly and efficiently evaluate chromatographic condition screening using promotable parameters and templates data acquisition, which promotes consistency of the method development process. |
|
|
|
|
|
|
|
|
|